Iejimalides

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameIejimalides
Drug Alias Nameiejimalide Biejimalide Aiejimalide Ciejimalide D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoclasts inhibitorsvacuolar H+-ATPase inhibitors
Targetsvacuolar H+-ATPase
Therapy Area/IndicationsOsteoporosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHokkaido University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHokkaido University
Active IndicationsN/A
Inactive IndicationsOsteoporosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A